Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Classifying Melanoma by TERT Promoter Mutational Status.

Shaughnessy M, Njauw CN, Artomov M, Tsao H.

J Invest Dermatol. 2019 Aug 16. pii: S0022-202X(19)32704-6. doi: 10.1016/j.jid.2019.06.149. [Epub ahead of print]

PMID:
31425705
2.

Growth suppression by dual BRAF(V600E) and NRAS(Q61) oncogene expression is mediated by SPRY4 in melanoma.

Kumar R, Njauw CN, Reddy BY, Ji Z, Rajadurai A, Klebanov N, Tsao H.

Oncogene. 2019 May;38(18):3504-3520. doi: 10.1038/s41388-018-0632-2. Epub 2019 Jan 16.

3.

Use of Targeted Next-Generation Sequencing to Identify Activating Hot Spot Mutations in Cherry Angiomas.

Klebanov N, Lin WM, Artomov M, Shaughnessy M, Njauw CN, Bloom R, Eterovic AK, Chen K, Kim TB, Tsao SS, Tsao H.

JAMA Dermatol. 2019 Feb 1;155(2):211-215. doi: 10.1001/jamadermatol.2018.4231.

PMID:
30601876
4.

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardière A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, Järvinen RS, van Doorn R, Jager MJ, Luyten GPM, Marinkovic M, Chau C, Potrony M, Höiom V, Helgadottir H, Pastorino L, Bruno W, Andreotti V, Dalmasso B, Ciccarese G, Queirolo P, Mastracci L, Wadt K, Kiilgaard JF, Speicher MR, van Poppelen N, Kilic E, Al-Jamal RT, Dianzani I, Betti M, Bergmann C, Santagata S, Dahiya S, Taibjee S, Burke J, Poplawski N, O'Shea SJ, Newton-Bishop J, Adlard J, Adams DJ, Lane AM, Kim I, Klebe S, Racher H, Harbour JW, Nickerson ML, Murali R, Palmer JM, Howlie M, Symmons J, Hamilton H, Warrier S, Glasson W, Johansson P, Robles-Espinoza CD, Ossio R, de Klein A, Puig S, Ghiorzo P, Nielsen M, Kivelä TT, Tsao H, Testa JR, Gerami P, Stern MH, Paillerets BB, Abdel-Rahman MH, Hayward NK.

J Natl Cancer Inst. 2018 Dec 1;110(12):1328-1341. doi: 10.1093/jnci/djy171. Review.

PMID:
30517737
5.

CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.

Karagianni F, Njauw CN, Kypreou KP, Stergiopoulou A, Plaka M, Polydorou D, Chasapi V, Pappas L, Stratigos IA, Champsas G, Panagiotou P, Gogas H, Evangelou E, Tsao H, Stratigos AJ, Stefanaki I.

Acta Derm Venereol. 2018 Oct 10;98(9):862-866. doi: 10.2340/00015555-2969.

6.

Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.

Artomov M, Stratigos AJ, Kim I, Kumar R, Lauss M, Reddy BY, Miao B, Daniela Robles-Espinoza C, Sankar A, Njauw CN, Shannon K, Gragoudas ES, Marie Lane A, Iyer V, Newton-Bishop JA, Timothy Bishop D, Holland EA, Mann GJ, Singh T, Daly MJ, Tsao H.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx083.

7.

High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.

Eliades P, Abraham BJ, Ji Z, Miller DM, Christensen CL, Kwiatkowski N, Kumar R, Njauw CN, Taylor M, Miao B, Zhang T, Wong KK, Gray NS, Young RA, Tsao H.

J Invest Dermatol. 2018 Jul;138(7):1582-1590. doi: 10.1016/j.jid.2017.09.056. Epub 2018 Feb 8.

8.

Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.

Haugh AM, Njauw CN, Bubley JA, Verzì AE, Zhang B, Kudalkar E, VandenBoom T, Walton K, Swick BL, Kumar R, Rana HQ, Cochrane S, McCormick SR, Shea CR, Tsao H, Gerami P.

JAMA Dermatol. 2017 Oct 1;153(10):999-1006. doi: 10.1001/jamadermatol.2017.2330. Review.

9.

Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation.

Gerami P, Yélamos O, Lee CY, Obregon R, Yazdan P, Sholl LM, Guitart GE, Njauw CN, Tsao H.

JAMA Dermatol. 2015 Nov;151(11):1235-9. doi: 10.1001/jamadermatol.2015.1701.

10.

Aggressive skull base metastasis from uveal melanoma: a clinicopathologic study.

Yonekawa Y, Kim IK, Gragoudas ES, Njauw CN, Tsao H, Jakobiec FA, Stacy RC.

Eur J Ophthalmol. 2014 Sep-Oct;24(5):811-3. doi: 10.5301/ejo.5000468. Epub 2014 May 12.

PMID:
24729140
11.

Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth.

Ji Z, Kumar R, Taylor M, Rajadurai A, Marzuka-Alcalá A, Chen YE, Njauw CN, Flaherty K, Jönsson G, Tsao H.

Clin Cancer Res. 2013 Aug 15;19(16):4383-91. doi: 10.1158/1078-0432.CCR-13-0074. Epub 2013 Jun 27.

12.

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.

Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H.

PLoS One. 2012;7(4):e35295. doi: 10.1371/journal.pone.0035295. Epub 2012 Apr 24.

13.

p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition.

Ji Z, Njauw CN, Taylor M, Neel V, Flaherty KT, Tsao H.

J Invest Dermatol. 2012 Feb;132(2):356-64. doi: 10.1038/jid.2011.313. Epub 2011 Oct 13.

14.

Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma.

Nikolaou V, Kang X, Stratigos A, Gogas H, Latorre MC, Gabree M, Plaka M, Njauw CN, Kypreou K, Mirmigi I, Stefanaki I, Tsao H.

Br J Dermatol. 2011 Dec;165(6):1219-22. doi: 10.1111/j.1365-2133.2011.10551.x. Epub 2011 Nov 2.

15.

EphA2 is a critical oncogene in melanoma.

Udayakumar D, Zhang G, Ji Z, Njauw CN, Mroz P, Tsao H.

Oncogene. 2011 Dec 15;30(50):4921-9. doi: 10.1038/onc.2011.210. Epub 2011 Jun 13.

16.

Agminated segmental nevi demonstrating intranevic concordance of BRAF status.

Luo S, Chaplin AC, Langley RG, Njauw CN, Duncan LM, Miller RA, Tsao H.

J Invest Dermatol. 2011 Mar;131(3):788-90. doi: 10.1038/jid.2010.380. Epub 2010 Dec 16. No abstract available.

17.

Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function.

Boni A, Cogdill AP, Dang P, Udayakumar D, Njauw CN, Sloss CM, Ferrone CR, Flaherty KT, Lawrence DP, Fisher DE, Tsao H, Wargo JA.

Cancer Res. 2010 Jul 1;70(13):5213-9. doi: 10.1158/0008-5472.CAN-10-0118. Epub 2010 Jun 15.

18.

Dynamic gene expression analysis links melanocyte growth arrest with nevogenesis.

Yang G, Thieu K, Tsai KY, Piris A, Udayakumar D, Njauw CN, Ramoni MF, Tsao H.

Cancer Res. 2009 Dec 1;69(23):9029-37. doi: 10.1158/0008-5472.CAN-09-0783. Epub 2009 Nov 10.

19.

EphA2 is an essential mediator of UV radiation-induced apoptosis.

Zhang G, Njauw CN, Park JM, Naruse C, Asano M, Tsao H.

Cancer Res. 2008 Mar 15;68(6):1691-6. doi: 10.1158/0008-5472.CAN-07-2372.

20.

A one-plasmid conditional color-switching transgenic system for multimodal bioimaging.

Zheng L, Njauw CN, Martins-Green M.

Transgenic Res. 2008 Aug;17(4):741-7. doi: 10.1007/s11248-007-9160-5. Epub 2008 Jan 9.

PMID:
18183494
21.

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling.

McDermott U, Sharma SV, Dowell L, Greninger P, Montagut C, Lamb J, Archibald H, Raudales R, Tam A, Lee D, Rothenberg SM, Supko JG, Sordella R, Ulkus LE, Iafrate AJ, Maheswaran S, Njauw CN, Tsao H, Drew L, Hanke JH, Ma XJ, Erlander MG, Gray NS, Haber DA, Settleman J.

Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19936-41. Epub 2007 Dec 6.

22.

Origin of periendothelial cells in microvessels derived from human microvascular endothelial cells.

Njauw CN, Yuan H, Zheng L, Yao M, Martins-Green M.

Int J Biochem Cell Biol. 2008;40(4):710-20. Epub 2007 Oct 22.

23.

A hCXCR1 transgenic mouse model containing a conditional color-switching system for imaging of hCXCL8/IL-8 functions in vivo.

Zheng L, Njauw CN, Martins-Green M.

J Leukoc Biol. 2007 Nov;82(5):1247-56. Epub 2007 Aug 17.

PMID:
17704296
24.

Cloning and characterization of the pheromone biosynthesis activating neuropeptide receptor gene in Spodoptera littoralis larvae.

Zheng L, Lytle C, Njauw CN, Altstein M, Martins-Green M.

Gene. 2007 May 15;393(1-2):20-30. Epub 2007 Jan 17.

PMID:
17379458

Supplemental Content

Loading ...
Support Center